诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301333 诺思格

交易中 12-24 11:01:39

{"stockData":{"symbol":"301333","market":"SZ","secType":"STK","nameCN":"诺思格","latestPrice":50.87,"timestamp":1735009299000,"preClose":51.05,"halted":0,"volume":183700,"delay":0,"floatShares":57312500,"shares":96581299,"eps":1.2538,"marketStatus":"交易中","marketStatusCode":2,"change":-0.18,"latestTime":"12-24 11:01:39","open":51.2,"high":51.85,"low":50.66,"amount":9441600,"amplitude":0.0233,"askPrice":50.93,"askSize":1,"bidPrice":50.75,"bidSize":6,"shortable":0,"etf":0,"ttmEps":1.2538,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1735011000000},"adr":0,"adjPreClose":51.05,"symbolType":"stock","openAndCloseTimeList":[[1735003800000,1735011000000],[1735016400000,1735023600000]],"highLimit":56.16,"lowLimit":45.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":96581256,"pbRate":2.76,"roa":"--","roe":"4.74%","epsLYR":2.08,"committee":0.666667,"marketValue":4913000000,"floatMarketCap":2915000000,"peRate":40.572658,"changeRate":-0.0035,"turnoverRate":0.0032,"status":1},"requestUrl":"/m/hq/s/301333/tweets","defaultTab":"tweets","newsList":[{"id":"2493755367","title":"海金格IPO投研报告：CRO遇冷为何业绩逆势增长？北交所两问真实合理性","url":"https://stock-news.laohu8.com/highlight/detail?id=2493755367","media":"时代周报-时代在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493755367?lang=zh_cn&edition=full","pubTime":"2024-12-23 19:30","pubTimestamp":1734953400,"startTime":"0","endTime":"0","summary":"2024年年中，海金格的IPO申报获北交所受理；12月12日，海金格回复了北交所的第二轮问询函。2024年上半年，三家同行可比公司扣非归母净利润均出现下滑，海金格却逆势高速增长，北交所连续两轮问询其业绩增长的真实合理性。海金格拟新增网点与部分分公司存在重合，但各地分公司现有人员数量较少，北交所询问新增网点是否存在闲置风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-23/doc-ineancvn9227140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03347","LU1820825898.SGD","BK1576","BK1583","LU1146622755.USD","BK1141","BK0028","BK0174","301333","BK0276","300347","301257","BK0216","688710","601066","BK0077"],"gpt_icon":0},{"id":"2490487400","title":"诺思格：该发明专利为公司内部使用，暂不对外授权。公司不会向IT方向转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2490487400","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490487400?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:00","pubTimestamp":1733994021,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格(301333)12月12日在投资者关系平台上答复投资者关心的问题。投资者：您好，注意到贵司24年5月申请了两个临床试验系统相关的发明专利，这对于对于公司业务是否有重大影响或帮助，后续公司考虑对外授予专利使用权吗？以及这是否意味着公司考虑向IT方向转型。谢谢！诺思格董秘：尊敬的投资者您好！该发明专利为公司内部使用，暂不对外授权。公司不会向IT方向转型。感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200027002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2490036078","title":"诺思格（301333）12月9日主力资金净卖出1082.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490036078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490036078?lang=zh_cn&edition=full","pubTime":"2024-12-10 09:20","pubTimestamp":1733793655,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月9日收盘，诺思格报收于57.44元，下跌3.14%，换手率2.73%，成交量1.57万手，成交额9216.37万元。近5日资金流向一览见下表：诺思格融资融券信息显示，融资方面，当日融资买入692.98万元，融资偿还431.18万元，融资净买入261.8万元。诺思格主营业务：临床试验运营服务、临床试验现场管理服务、生物样本检测服务、数据管理与统计分析服务、临床试验咨询服务、临床药理学服务等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000010202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2489421294","title":"诺思格（301333）12月5日主力资金净卖出854.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489421294","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489421294?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:19","pubTimestamp":1733447975,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月5日收盘，诺思格报收于57.68元，下跌2.24%，换手率1.35%，成交量7725.0手，成交额4509.47万元。近5日资金流向一览见下表：诺思格融资融券信息显示，融资方面，当日融资买入270.42万元，融资偿还265.25万元，融资净买入5.16万元。诺思格主营业务：临床试验运营服务、临床试验现场管理服务、生物样本检测服务、数据管理与统计分析服务、临床试验咨询服务、临床药理学服务等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600008861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2488618620","title":"华安证券：给予诺思格增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2488618620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488618620?lang=zh_cn&edition=full","pubTime":"2024-12-02 07:50","pubTimestamp":1733097023,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超近期对诺思格进行研究并发布了研究报告《临床CRO领先企业，稳步提升运营效率》，本报告对诺思格给出增持评级，当前股价为60.81元。3）临床试验需求依旧强劲，药品注册申请申报量持续增长。随行业需求端的逐步回暖，该业务板块有望进一步修复。首次覆盖，给予“增持”评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家；过去90天内机构目标均价为67.0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200000875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","301333"],"gpt_icon":0},{"id":"2484453165","title":"11月20日诺思格涨7.34%，广发聚丰混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484453165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484453165?lang=zh_cn&edition=full","pubTime":"2024-11-20 16:14","pubTimestamp":1732090469,"startTime":"0","endTime":"0","summary":"证券之星消息，11月20日诺思格涨7.34%，收盘报59.4元，换手率4.56%，成交量2.62万手，成交额1.56亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为广发聚丰混合A。广发聚丰混合A目前规模为22.02亿元，最新净值0.5277，较上一交易日上涨2.93%，近一年下跌21.09%。广发聚丰混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000026854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2484165441","title":"诺思格涨7.34%，开源证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2484165441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484165441?lang=zh_cn&edition=full","pubTime":"2024-11-20 16:14","pubTimestamp":1732090460,"startTime":"0","endTime":"0","summary":"今日诺思格涨7.34%，收盘报59.4元。2024年11月3日，开源证券研究员余汝意,汪晋发布了对诺思格的研报《公司信息更新报告：前三季度收入稳健增长，受股份支付影响利润端承压》，该研报对诺思格给出“买入”评级。研报中预计2024-2026年归母净利润为1.37/2.00/2.52亿元，EPS为1.42/2.07/2.61元，当前股价对应PE为41.0/28.1/22.3倍，维持“买入”评级。诺思格个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000026846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301333"],"gpt_icon":0},{"id":"2484090918","title":"诺思格：关于独立董事辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2484090918","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484090918?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:41","pubTimestamp":1732009260,"startTime":"0","endTime":"0","summary":"诺思格（北京）医药科技股份有限公司关于独立董事辞职的公告近日，诺思格（北京）医药科技股份有限公司董事会收到公司独立董事李峰先生的书面辞职申请，李峰先生因个人原因辞去公司第五届董事会独立董事及董事会审计委员会主任委员、薪酬与考核委员会委员职务。在新任独立董事就任前，李峰先生将按照相关法律法规及《公司章程》的规定，继续履行独立董事及其在董事会相关专门委员会中的职责。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-19/doc-incwqvpq2923602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2484508930","title":"诺思格（301333）11月18日主力资金净卖出722.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484508930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484508930?lang=zh_cn&edition=full","pubTime":"2024-11-19 09:21","pubTimestamp":1731979313,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月18日收盘，诺思格报收于53.85元，下跌8.78%，换手率3.79%，成交量2.17万手，成交额1.21亿元。近5日资金流向一览见下表：诺思格融资融券信息显示，融资方面，当日融资买入398.73万元，融资偿还570.36万元，融资净偿还171.63万元。诺思格主营业务：临床试验运营服务、临床试验现场管理服务、生物样本检测服务、数据管理与统计分析服务、临床试验咨询服务、临床药理学服务等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900008254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2484610971","title":"11月18日诺思格跌8.78%，广发聚丰混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484610971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484610971?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:24","pubTimestamp":1731918280,"startTime":"0","endTime":"0","summary":"证券之星消息，11月18日诺思格跌8.78%，收盘报53.85元，换手率3.79%，成交量2.17万手，成交额1.21亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为广发聚丰混合A。广发聚丰混合A目前规模为22.02亿元，最新净值0.5196，较上一交易日下跌2.26%，近一年下跌22.77%。广发聚丰混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800020048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2483579870","title":"诺思格最新公告：持股5%以上股东拟减持不超过2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483579870","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483579870?lang=zh_cn&edition=full","pubTime":"2024-11-14 21:11","pubTimestamp":1731589864,"startTime":"0","endTime":"0","summary":"诺思格公告，持股5%以上的股东和谐成长二期投资中心与珠海和谐康健投资基金计划在未来三个月内通过大宗交易及集中竞价方式分别减持不超过2.7%的公司股份。和谐成长二期当前持有诺思格股份480万股，占总股本比例5.05%，而和谐康健持有215.52万股，占总股本比例2.27%。减持计划已向中国证券投资基金业协会备案，并符合相关减持规定。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400035951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2483877760","title":"诺思格(301333.SZ)股东和谐成长二期、和谐康健拟减持不超256万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877760","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483877760?lang=zh_cn&edition=full","pubTime":"2024-11-14 21:03","pubTimestamp":1731589437,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺思格(301333.SZ)公告，公司股东和谐成长二期、和谐康健拟减持公司股份，合计数量不超256万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2483092360","title":"诺思格（301333）11月12日主力资金净卖出2177.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483092360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483092360?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:22","pubTimestamp":1731460940,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月12日收盘，诺思格报收于66.4元，下跌4.82%，换手率4.84%，成交量2.77万手，成交额1.91亿元。近5日资金流向一览见下表：诺思格融资融券信息显示，融资方面，当日融资买入1060.76万元，融资偿还3245.67万元，融资净偿还2184.91万元。诺思格主营业务：临床试验运营服务、临床试验现场管理服务、生物样本检测服务、数据管理与统计分析服务、临床试验咨询服务、临床药理学服务等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300008315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2481570157","title":"诺思格(301333.SZ)已耗资5606.27万元回购1.49%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2481570157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481570157?lang=zh_cn&edition=full","pubTime":"2024-11-05 20:15","pubTimestamp":1730808916,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺思格(301333.SZ)发布公告，截至2024年10月31日，公司通过回购专用证券账户以集中竞价交易方式已累计回购公司股份144.20万股，约占公司目前总股本的1.49%。最高成交价为43.15元/股，最低成交价为35.06元/股，成交总金额为5606.27万元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207099.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2481952576","title":"11月5日诺思格涨14.35%，广发聚丰混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481952576","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481952576?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:25","pubTimestamp":1730795134,"startTime":"0","endTime":"0","summary":"证券之星消息，11月5日诺思格涨14.35%，收盘报66.29元，换手率5.55%，成交量3.18万手，成交额1.97亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为广发聚丰混合A。广发聚丰混合A目前规模为22.02亿元，最新净值0.5111，较上一交易日上涨1.63%，近一年下跌20.85%。广发聚丰混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500026305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2481254135","title":"诺思格涨14.35%，开源证券二日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481254135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481254135?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:25","pubTimestamp":1730795128,"startTime":"0","endTime":"0","summary":"今日诺思格涨14.35%，收盘报66.29元。2024年11月3日，开源证券研究员余汝意,汪晋发布了对诺思格的研报《公司信息更新报告：前三季度收入稳健增长，受股份支付影响利润端承压》，该研报对诺思格给出“买入”评级。研报中预计2024-2026年归母净利润为1.37/2.00/2.52亿元，EPS为1.42/2.07/2.61元，当前股价对应PE为41.0/28.1/22.3倍，维持“买入”评级。诺思格个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500026302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301333"],"gpt_icon":0},{"id":"2480636626","title":"开源证券：给予诺思格买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480636626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480636626?lang=zh_cn&edition=full","pubTime":"2024-11-03 21:11","pubTimestamp":1730639477,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对诺思格进行研究并发布了研究报告《公司信息更新报告：前三季度收入稳健增长，受股份支付影响利润端承压》，本报告对诺思格给出买入评级，当前股价为58.07元。公司积极推进员工持股计划，有助于加强管理层与核心技术人员的稳定性，为公司长远发展保驾护航。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家；过去90天内机构目标均价为53.5。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110300001829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","161027"],"gpt_icon":0},{"id":"2480796410","title":"11月1日诺思格跌5.78%，广发聚丰混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480796410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480796410?lang=zh_cn&edition=full","pubTime":"2024-11-01 16:33","pubTimestamp":1730450010,"startTime":"0","endTime":"0","summary":"证券之星消息，11月1日诺思格跌5.78%，收盘报58.07元，换手率3.04%，成交量1.74万手，成交额1.03亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为广发聚丰混合A。广发聚丰混合A目前规模为22.02亿元，最新净值0.5096，较上一交易日上涨1.03%，近一年下跌21.05%。广发聚丰混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100030033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2479705031","title":"太平洋：给予诺思格买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479705031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479705031?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:26","pubTimestamp":1730370380,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司周豫,张崴近期对诺思格进行研究并发布了研究报告《收入增速符合预期，股权激励影响利润》，本报告对诺思格给出买入评级，当前股价为61.63元。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家；过去90天内机构目标均价为53.5。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100037988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301333"],"gpt_icon":0},{"id":"2479379815","title":"诺思格（301333）2024年三季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2479379815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479379815?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:47","pubTimestamp":1730328435,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期诺思格发布2024年三季报。根据财报显示，诺思格增收不增利。截至本报告期末，公司营业总收入5.62亿元，同比上升7.1%，归母净利润8441.72万元，同比下降32.93%。按单季度数据看，第三季度营业总收入1.83亿元，同比上升12.42%，第三季度归母净利润2590.67万元，同比下降35.04%。持有诺思格最多的基金为广发聚丰混合A，目前规模为22.02亿元，最新净值0.5044，较上一交易日下跌0.34%，近一年下跌20.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-08-02","address":"北京市通州区经济开发区东区创益西路518号","stockEarnings":[{"period":"1week","weight":-0.0667},{"period":"1month","weight":-0.126},{"period":"3month","weight":0.2891},{"period":"6month","weight":0.4495},{"period":"1year","weight":-0.1563},{"period":"ytd","weight":-0.2035}],"companyName":"诺思格(北京)医药科技股份有限公司","boardCode":"AI0073","perCapita":"9820股","boardName":"研究和试验发展","registeredCapital":"9658万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":"　　诺思格(北京)医药科技股份有限公司主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。主要产品及服务是临床试验运营服务（“CO服务”）、临床试验现场管理服务（“SMO服务”）、生物样本检测服务（“BA服务”）、数据管理与统计分析服务（“DM/ST服务”）、临床试验咨询服务、临床药理学服务（“CP服务”）。","serverTime":1735009305191,"listedPrice":78.88,"stockholders":"5836人(较上一季度减少25.11%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺思格,301333,诺思格股票,诺思格股票老虎,诺思格股票老虎国际,诺思格行情,诺思格股票行情,诺思格股价,诺思格股市,诺思格股票价格,诺思格股票交易,诺思格股票购买,诺思格股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}